Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J A Welsh

Showing results (11-20 of 44) with videos related to

Pageof 5
Sort By:
Oncology Research|May 1, 1999
Infrequent p53 mutations in arsenic-related skin lesionsK Castrén, A Ranki, J A Welsh, et al.
Carcinogenesis|November 1, 1995
p53 mutations in primary hepatic angiosarcomas not associated with vinyl chloride exposureY Soini, J A Welsh, K G Ishak, et al.
Carcinogenesis|January 1, 1996
p53 mutations in hepatocellular carcinoma related to oral contraceptive useV M De Benedetti, J A Welsh, M C Yu, et al.
The Journal of Biological Chemistry|May 15, 1987
Evolution of the immunodominant domain of the circumsporozoite protein gene from Plasmodium vivax. Implications for vaccinesV F de la Cruz, A A Lal, J A Welsh, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 1, 1990
Frequent mutation of the p53 gene in human esophageal cancerM C Hollstein, R A Metcalf, J A Welsh, et al.
Nature|April 4, 1991
Mutational hotspot in the p53 gene in human hepatocellular carcinomasI C Hsu, R A Metcalf, T Sun, et al.
Carcinogenesis|May 1, 1993
p53 gene mutation and integrated hepatitis B viral DNA sequences in human liver cancer cell linesI C Hsu, T Tokiwa, W Bennett, et al.
The Journal of Biological Chemistry|March 5, 1987
Structure of the gene encoding the circumsporozoite protein of Plasmodium yoelii. A rodent model for examining antimalarial sporozoite vaccinesA A Lal, V F de la Cruz, J A Welsh, et al.
Cancer Research|February 1, 1997
Integrity of p53 in hepatitis B x antigen-positive and -negative hepatocellular carcinomasM S Greenblatt, M A Feitelson, M Zhu, et al.
Cancer Research|August 1, 1991
Genetic analysis of human esophageal tumors from two high incidence geographic areas: frequent p53 base substitutions and absence of ras mutationsM C Hollstein, L Peri, A M Mandard, et al.
Pageof 5

Showing results (11-20 of 44) with videos related to

Sort By:
Pageof 5
Oncology Research|May 1, 1999
Infrequent p53 mutations in arsenic-related skin lesionsK Castrén, A Ranki, J A Welsh, et al.
Carcinogenesis|November 1, 1995
p53 mutations in primary hepatic angiosarcomas not associated with vinyl chloride exposureY Soini, J A Welsh, K G Ishak, et al.
Carcinogenesis|January 1, 1996
p53 mutations in hepatocellular carcinoma related to oral contraceptive useV M De Benedetti, J A Welsh, M C Yu, et al.
The Journal of Biological Chemistry|May 15, 1987
Evolution of the immunodominant domain of the circumsporozoite protein gene from Plasmodium vivax. Implications for vaccinesV F de la Cruz, A A Lal, J A Welsh, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 1, 1990
Frequent mutation of the p53 gene in human esophageal cancerM C Hollstein, R A Metcalf, J A Welsh, et al.
Nature|April 4, 1991
Mutational hotspot in the p53 gene in human hepatocellular carcinomasI C Hsu, R A Metcalf, T Sun, et al.
Carcinogenesis|May 1, 1993
p53 gene mutation and integrated hepatitis B viral DNA sequences in human liver cancer cell linesI C Hsu, T Tokiwa, W Bennett, et al.
The Journal of Biological Chemistry|March 5, 1987
Structure of the gene encoding the circumsporozoite protein of Plasmodium yoelii. A rodent model for examining antimalarial sporozoite vaccinesA A Lal, V F de la Cruz, J A Welsh, et al.
Cancer Research|February 1, 1997
Integrity of p53 in hepatitis B x antigen-positive and -negative hepatocellular carcinomasM S Greenblatt, M A Feitelson, M Zhu, et al.
Cancer Research|August 1, 1991
Genetic analysis of human esophageal tumors from two high incidence geographic areas: frequent p53 base substitutions and absence of ras mutationsM C Hollstein, L Peri, A M Mandard, et al.
Pageof 5